SEC Filing Document

Company: BIOVENTRIX, INC.
Ticker: 
CIK: 1283259
Filing Type: S-1/A
Document Type: EX-10.12
Date Filed: 2026-05-15
Accession Number: 0001493152-26-023752
Exchange: 
SIC Code: 3841
SIC Description: Surgical & Medical Instruments & Apparatus
URL: https://www.sec.gov/Archives/edgar/data/1283259/000149315226023752/ex10-12.htm

Chunk 7 of 8
Word Count: 503
Character Count: 3135

Document Content:

and understands its terms and effects, including the fact that the undersigned agreed to release and forever discharge the Company and each of the Releasees, from any Claims released in this Release; b. the undersigned understands that, by entering into this Release, the undersigned does not waive any Claims that may arise after the date of the undersigned’s execution of this Release, including without limitation any rights or claims that the undersigned may have to secure enforcement of the terms and conditions of this Release; c. the undersigned has signed this Release voluntarily and knowingly in exchange for the consideration described in this Release, which the undersigned acknowledges is adequate and satisfactory to the undersigned and which the undersigned acknowledges is in addition to any other benefits to which the undersigned is otherwise entitled; d. the Company advises the undersigned to consult with an attorney prior to executing this Release;

e.	the undersigned has been
given at least [21]-days in which to review and consider this Release. To the extent that the undersigned chooses to sign this Release
prior to the expiration of such period, the undersigned acknowledges that the undersigned has done so voluntarily, had sufficient time
to consider the Release, to consult with counsel and that the undersigned does not desire additional time and hereby waives the remainder
of the [21]-day period; and

f.	the undersigned may revoke
this Release within seven days from the date the undersigned signs this Release and this Release will become effective upon the expiration
of that revocation period if the undersigned has not revoked this Release during such seven-day period. If the undersigned revokes
this Release during such seven-day period, this Release will be null and void and of no force or effect on either the Company or the
undersigned and the undersigned will not be entitled to any of the payments or benefits which are expressly conditioned upon the execution
and non-revocation of this Release. Any revocation must be in writing and sent to [ name ], via electronic mail at [ email address ],
on or before [5:00 p.m. Eastern time] on the seventh day after this Release is executed by the undersigned.

Acknowledgement. The undersigned acknowledges that different or additional facts may be discovered in addition to what is now
known or believed to be true by the undersigned with respect to the matters released in this Release, and the undersigned agrees that
this Release shall be and remain in effect in all respects as a complete and final release of the matters released, notwithstanding any
different or additional facts.

Governing Law. This Release is deemed made and entered into in the State of Delaware, and in all respects shall be interpreted,
enforced and governed under the internal laws of the State of Delaware, to the extent not preempted by federal law.

Exhibit A - Employment Agreement – Carl Byrnes

WITNESS WHEREOF, the undersigned has executed this Release this___________ day of _________________.

Carl Byrnes

Exhibit A - Employment Agreement – Carl Byrnes